MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Mucocele

(UMLS:C0026683)

Definition:: A retention cyst of the salivary gland, lacrimal sac, paranasal sinuses, appendix, or gallbladder. (Stedman, 26th ed)
UMLS ID:: C0026683
MeSH ID:: D009078

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.182.511

Synonym(s)

Mucocele

MUCOCELE

Mucinous cyst

Mucous Cyst

Mucous cyst

Mucous retention cyst

Mucus Cyst

Mucus cyst

mucinous cyst

10.

mucocele

11.

mucoceles

12.

mucous cyst

13.

mucous retention cyst

14.

mucus cyst

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Famotidine	18518811	CTD
2	Fatty Acids, Omega-3	18518811	CTD
3	Fenbendazole	18518811	CTD
4	S-Adenosylmethionine	18518811	CTD
5	Thyroxine	18518811	CTD
6	Ursodeoxycholic Acid	18518811	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Follicular cyst	42.9%
2	Pilonidal Cyst	42.9%
3	Thyroglossal Cyst	42.9%
4	Synovial Cyst	42.9%
5	Dermoid Cyst	33.3%
6	Lymphocele	28.6%
7	Pancreatic Cyst	28.6%
8	Breast Cyst	27.9%
9	Mediastinal Cyst	27.9%
10	Parovarian Cyst	27.9%
11	Pericardial Cyst	27.9%
12	Thymic Cyst	27.9%
13	Myxoid cyst	27.9%
14	Hamartoma	23.1%
15	Neoplasms, Hormone-Dependent	23.1%
16	Neoplasms, Multiple Primary	23.1%
17	Paraneoplastic Syndromes	23.1%
18	Precancerous Conditions	23.1%
19	Neoplasms, Second Primary	23.1%
20	Pancreatic Pseudocyst	20.5%
21	Corpus Luteum Cyst	20.4%
22	Ovarian Cysts	20.4%
23	Choledochal Cyst	16.7%
24	Neoplastic Processes	15%
25	Neoplastic Syndromes, Hereditary	15%
26	Pregnancy Complications, Neoplastic	15%
27	Carcinoma, Ehrlich Tumor	14.9%
28	Carcinoma, Lewis Lung	14.9%
29	Polycystic Ovary Syndrome	14.9%
30	Carcinoma 256, Walker	14.8%
31	Neoplasms, Experimental	14.6%
32	Abdominal Neoplasms	14.3%
33	Erythroplasia	14.3%
34	Head and Neck Neoplasms	14.3%
35	leukemia	14.3%
36	Neoplasms, Germ Cell and Embryonal	14.3%
37	Neoplasms, Glandular and Epithelial	14.3%
38	Soft Tissue Neoplasms	14.3%
39	Thoracic Neoplasms	14.3%
40	Germ Cell Cancer	14.3%
41	Aberrant Crypt Foci	14.3%
42	Neuroectodermal Tumors	13.6%
43	Neoplasms, Neuroepithelial	13.3%
44	Gliomatosis cerebri	13.3%
45	Multiple Endocrine Neoplasia	12.8%
46	melanoma	12.4%
47	Carcinosarcoma	12.4%
48	Hemangiosarcoma	12.4%
49	Leukemia L1210	12.4%
50	Leukemia P388	12.4%
51	lymphangiosarcoma	12.4%
52	Acanthoma	12.4%
53	Paraneoplastic Encephalomyelitis	12.3%
54	Trophoblastic Neoplasms	12.1%
55	Leukemia, Experimental	12%
56	Mammary Neoplasms, Experimental	12%
57	Medulloblastoma	11.9%
58	Melanoma, Experimental	11.8%
59	Sarcoma 180	11.7%
60	Adenoma, Acidophil	11.5%
61	Ganglioneuroma	11.5%
62	Glioma	11.5%
63	Malignant Glioma	11.5%
64	Basal cell carcinoma	11.1%
65	Carcinoma, Papillary	11.1%
66	Squamous cell carcinoma	11.1%
67	Chondrosarcoma	11.1%
68	Craniopharyngioma	11.1%
69	Cystadenoma	11.1%
70	leiomyosarcoma	11.1%
71	liposarcoma	11.1%
72	Mesothelioma	11.1%
73	synovial sarcoma	11.1%
74	Neuroectodermal Tumor, Melanotic	11.1%
75	Angiomyolipoma	11.1%
76	Clear Cell Sarcoma of Soft Tissue	11.1%
77	Alveolar Soft Part Sarcoma	11.1%
78	Neuroendocrine Tumors	11.1%
79	Sarcoma, Myeloid	11.1%
80	Carcinoma, Basal Cell	11.1%
81	Carcinoid Tumor	11%
82	Neurilemmoma	11%
83	Hutchinson's Melanotic Freckle	11%
84	Melanoma, Amelanotic	11%
85	Sarcoma, Experimental	11%
86	Meningioma	11%
87	Neoplasms, Radiation-Induced	10.8%
88	Astrocytoma	10.6%
89	Ependymoma	10.6%
90	oligodendroglioma	10.6%
91	Ganglioglioma	10.6%
92	gliosarcoma	10.6%
93	Anaplastic astrocytoma	10.6%
94	Anaplastic Oligodendroglioma	10.6%
95	Cystadenocarcinoma	10.5%
96	Fibrosarcoma	10.5%
97	Osteosarcoma	10.5%
98	Mucoepidermoid Carcinoma	10.5%
99	Adenoma	10.3%
100	Ameloblastoma	10.3%
101	Angiokeratoma	10.3%
102	Carcinoma	10.3%
103	Chordoma	10.3%
104	Hemangioma	10.3%
105	hemangiopericytoma	10.3%
106	Lymphangioma	10.3%
107	Malignant Carcinoid Syndrome	10.3%
108	Mesenchymoma	10.3%
109	Nevus	10.3%
110	Retroperitoneal Neoplasms	10.3%
111	Teratoma	10.3%
112	Hepatoblastoma	10.3%
113	Mixed Tumor, Mullerian	10.3%
114	Germinoma	10.3%
115	Teratocarcinoma	10.3%
116	Angiofibroma	10.3%
117	Sarcoma	10.3%
118	Epithelioma	10.3%
119	Choriocarcinoma	10.2%
120	Carcinoma, Lobular	10.2%
121	Adenofibroma	10.2%
122	Fibroadenoma	10.2%
123	Malignant Fibrous Histiocytoma	10.2%
124	Glioblastoma	10.1%
125	Neuroblastoma	10.1%
126	Glioblastoma Multiforme	10.1%
127	Basal Cell Nevus Syndrome	10.1%
128	Digestive System Neoplasms	10%
129	Endocrine Gland Neoplasms	10%
130	Eye Neoplasms	10%
131	Nervous System Neoplasms	10%
132	Ganglioneuroblastoma	9.9%
133	Bowen's Disease	9.9%
134	Paraganglioma	9.9%
135	Rhabdomyosarcoma	9.9%
136	Giant Cell Tumor of Bone	9.9%
137	Leukemia, Radiation-Induced	9.7%
138	Dermatofibrosarcoma	9.6%
139	Dermatofibrosarcoma Protuberans	9.6%
140	Bone neoplasms	9.5%
141	Leukoplakia	9.5%
142	Skin Neoplasms	9.5%
143	Hematologic Neoplasms	9.5%
144	Multiple Endocrine Neoplasia Type 1	9.4%
145	Barrett Esophagus	9.3%
146	Histiocytic Disorders, Malignant	9.3%
147	Actinic keratosis	9.3%
148	Neoplasm Invasiveness	9.3%
149	Neoplasm Metastasis	9.3%
150	Neoplasm Recurrence, Local	9.3%
151	Splenic Neoplasms	9.3%
152	Carcinogenesis	9.3%
153	Metastasis	9.3%
154	Pheochromocytoma	9.3%
155	Alveolar rhabdomyosarcoma	9.3%
156	Thymoma	9.2%
157	Leukemia, Plasma Cell	9.2%
158	Adenocarcinoma	8.5%
159	Carcinoma in Situ	8.5%
160	Carcinoma, Transitional Cell	8.5%
161	Phyllodes Tumor	8.5%
162	Dysgerminoma	8.5%
163	Hemangioendothelioma	8.5%
164	Lipoma	8.5%
165	Myoma	8.5%
166	Myxoma	8.5%
167	Neuroma	8.5%
168	Papilloma	8.5%
169	Pseudomyxoma Peritonei	8.5%
170	Seminoma	8.5%
171	Papillomatosis	8.5%
172	Angiolipoma	8.5%
173	Myelolipoma	8.5%
174	Neoplasms, Bone Tissue	8.5%
175	Neoplasms, Fibrous Tissue	8.5%
176	Smooth Muscle Tumor	8.5%
177	Adenomatosis, Pulmonary	8.5%
178	Adenomatous Polyps	8.5%
179	Carcinoma, Large Cell	8.5%
180	Carcinoma, Small Cell	8.5%
181	Desmoplastic Small Round Cell Tumor	8.5%
182	Chondroma	8.5%
183	Enchondroma	8.5%
184	Parathyroid Neoplasms	8.3%
185	Peritoneal Neoplasms	8.3%
186	Thyroid Neoplasm	8.3%
187	Thyroid carcinoma	8.3%
188	Lymphomatoid Granulomatosis	8.3%
189	Tuberous Sclerosis	8.2%
190	Carcinoid Heart Disease	8.2%
191	Composite Lymphoma	8%
192	Retinoblastoma	7.9%
193	Hydatidiform Mole	7.8%
194	Carcinoma, Pancreatic Ductal	7.7%
195	Tracheal Neoplasms	7.6%
196	Adenoid Cystic Carcinoma	7.6%
197	fibroma	7.6%
198	Fibromatosis	7.6%
199	Osteoblastoma	7.6%
200	Osteoma	7.6%
201	Rhabdomyoma	7.6%
202	Chondromatosis	7.6%
203	Adenocarcinoma, Clear Cell	7.6%
204	Cholangiocarcinoma	7.6%
205	Cervical Intraepithelial Neoplasia	7.6%
206	Hemangioblastoma	7.6%
207	Lymphoma, Extranodal NK-T-Cell	7.6%
208	Leukoplakia, Oral	7.4%
209	Paraneoplastic Cerebellar Degeneration	7.3%
210	Liver Neoplasms, Experimental	7.3%
211	Acoustic Neuroma	7.3%
212	Neurofibrosarcoma	7.1%
213	Fibromatosis, Aggressive	7.1%
214	Fibromatosis, Abdominal	7.1%
215	Klatskin Tumor	7.1%
216	Vipoma	7.1%
217	Mouth Neoplasms	7%
218	Pancreatic Neoplasm	7%
219	Central Nervous System Neoplasms	7%
220	Vascular Neoplasms	7%
221	Thymus Neoplasms	7%
222	Radicular Cyst	6.9%
223	Lymphoma	6.9%
224	Endometrial Stromal Sarcoma	6.9%
225	Genital Neoplasms, Female	6.8%
226	Plasmacytoma	6.8%
227	Nephroblastoma	6.8%
228	Malignant histiocytosis	6.7%
229	Lymphatic Metastasis	6.7%
230	Neoplasms, Unknown Primary	6.7%
231	Leukemic Infiltration	6.7%
232	Breast Neoplasms, Male	6.7%
233	Histiocytic sarcoma	6.7%
234	Neoplasm Micrometastasis	6.7%
235	Triple Negative Breast Neoplasms	6.7%
236	Thyroid Nodule	6.7%
237	Hepatocellular Adenoma	6.7%
238	Lymphangioleiomyomatosis	6.6%
239	Optic Nerve Glioma	6.4%
240	insulinoma	6.3%
241	Esophageal Neoplasms	6.1%
242	Gastrinoma	6.1%
243	Glucagonoma	6.1%
244	Limbic Encephalitis	6.1%
245	Meningeal Neoplasms	5.6%
246	Leukemia, Myelomonocytic, Chronic	5.6%
247	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	5.6%
248	Prolactinoma	5.5%
249	Growth Hormone-Secreting Pituitary Adenoma	5.5%
250	Adenomatous Polyposis Coli	5.5%
251	Peutz-Jeghers Syndrome	5.4%
252	Leydig Cell Tumor	5.3%
253	Lambert-Eaton Myasthenic Syndrome	5.3%
254	Testicular Neoplasms	5.3%
255	Adrenal Gland Neoplasms	5.3%
256	Gastrointestinal Neoplasms	5.3%
257	Genital Neoplasms, Male	5.3%
258	Liver neoplasms	5.3%
259	Uveal Neoplasms	5.3%
260	Urologic Neoplasms	5.2%
261	Sebaceous Gland Neoplasms	5.1%
262	Spinal Neoplasms	5.1%
263	Bone Marrow Neoplasms	5.1%
264	Mastocytoma	5%
265	Hodgkin Disease	5%
266	Lymphoma, Non-Hodgkin	5%
267	Meningeal Carcinomatosis	5%
268	Mastocytosis, Systemic	5%
269	Leukemia, Myeloid, Chronic-Phase	4.9%
270	Mesoblastic Nephroma	4.9%
271	Adrenocortical carcinoma	4.9%
272	granulosa cell tumor	4.7%
273	Carcinoma, Ovarian Epithelial	4.7%
274	Opsoclonus-Myoclonus Syndrome	4.6%
275	Palatal Neoplasms	4.5%
276	Ear Neoplasms	4.3%
277	Eyelid Neoplasms	4.3%
278	Lung Neoplasms	4.3%
279	Pleural Neoplasms	4.3%
280	Nose Neoplasms	4.3%
281	Mastocytosis	4.3%
282	Sturge-Weber Syndrome	4.3%
283	Cell Transformation, Viral	4.2%
284	Brain Neoplasms	4.2%
285	Salivary Gland Neoplasms	4.2%
286	Spinal Cord Neoplasms	4.2%
287	Tongue Neoplasms	4.2%
288	Gastrointestinal Stromal Tumors	4.2%
289	Renal Cell Carcinoma	4.2%
290	Hemangioma, Cavernous	4.2%
291	Papillary Renal Cell Carcinoma	4.2%
292	Leukemia, T-Cell	4.1%
293	Uterine Neoplasms	4.1%
294	Vaginal Neoplasms	4.1%
295	Vulvar Neoplasms	4.1%
296	Uterine Cancer	4.1%
297	Leukemia, B-Cell	4.1%
298	Fallopian Tube Neoplasms	4.1%
299	neurofibroma	4.1%
300	Lymphoma, Follicular	4.1%
301	T-Cell Lymphoma	4.1%
302	Mantle cell lymphoma	4.1%
303	Myelitis, Transverse	4%
304	Carcinoma, Endometrioid	4%
305	Primary amyloidosis	4%
306	Bronchial Neoplasms	3.8%
307	Denys-Drash Syndrome	3.8%
308	Multiple Pulmonary Nodules	3.8%
309	Nasopharyngeal carcinoma	3.8%
310	Pituitary Adenoma	3.7%
311	Pituitary Neoplasms	3.7%
312	Supratentorial Neoplasms	3.7%
313	Endometrial Neoplasms	3.7%
314	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	3.7%
315	Leukemia, Large Granular Lymphocytic	3.7%
316	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3.7%
317	Lymphoma, T-Cell, Cutaneous	3.7%
318	Lymphoma, AIDS-Related	3.7%
319	Enteropathy-Associated T-Cell Lymphoma	3.7%
320	Primary Effusion Lymphoma	3.7%
321	Dupuytren Contracture	3.6%
322	Urticaria Pigmentosa	3.5%
323	Pharyngeal Neoplasms	3.5%
324	Brain Stem Neoplasms	3.5%
325	Mycosis Fungoides	3.4%
326	Lymphomatoid Papulosis	3.4%
327	Plasmablastic lymphoma	3.4%
328	Central Nervous System Cysts	3.4%
329	ovarian neoplasm	3.4%
330	Bile Duct Neoplasms	3.4%
331	gallbladder neoplasm	3.4%
332	Intestinal Neoplasms	3.4%
333	Penile Neoplasms	3.4%
334	Prostatic Neoplasms	3.4%
335	Stomach Neoplasms	3.4%
336	Choroid Plexus Papilloma	3.3%
337	Polycythemia Vera	3.3%
338	Hypopharyngeal Neoplasms	3%
339	Pleural Effusion, Malignant	3%
340	Hypopharyngeal Cancer	3%
341	Xeroderma Pigmentosum	3%
342	Parotid Neoplasms	3%
343	Prostatic Neoplasms, Castration-Resistant	3%
344	Nelson Syndrome	2.9%
345	Laryngeal neoplasm	2.9%
346	Waldenstrom Macroglobulinemia	2.9%
347	Multiple Myeloma	2.9%
348	Tonsillar Neoplasms	2.8%
349	Cerebellar Neoplasms	2.8%
350	Bladder Neoplasm	2.8%
351	Kidney Neoplasm	2.8%
352	Ureteral Neoplasms	2.8%
353	Urethral Neoplasms	2.8%
354	Zollinger-Ellison syndrome	2.5%
355	Cecal Neoplasms	2.5%
356	Duodenal Neoplasms	2.5%
357	Burkitt Lymphoma	2.4%
358	Sezary Syndrome	2.3%
359	Appendiceal Neoplasms	2.3%
360	Colonic Neoplasms	2.3%
361	Rectal Neoplasms	2.3%
362	Nasopharyngeal Neoplasms	2.1%
363	Colorectal Neoplasms	2.1%
364	Anus Neoplasms	1.9%
365	Sigmoid Neoplasms	1.9%
366	Paranasal Sinus Neoplasms	1.9%
367	Maxillary Sinus Neoplasms	1.7%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234